-
2
-
-
45849101195
-
Extraintestinal manifestations of inflammatory bowel disease
-
Ardizzone S., Puttini P.S., Cassinotti A., Porro G.B. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 2008, 40(Suppl 2):S253-S2599.
-
(2008)
Dig Liver Dis
, vol.40
, Issue.SUPPL 2
-
-
Ardizzone, S.1
Puttini, P.S.2
Cassinotti, A.3
Porro, G.B.4
-
3
-
-
60749113903
-
Extraintestinal manifestations of inflammatory bowel disease
-
Williams H., Walker D., Orchard T.R. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008, 10:597-605.
-
(2008)
Curr Gastroenterol Rep
, vol.10
, pp. 597-605
-
-
Williams, H.1
Walker, D.2
Orchard, T.R.3
-
4
-
-
0346665684
-
Pulmonary manifestations of inflammatory bowel disease
-
Storch I., Sachar D., Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003, 9:104-115.
-
(2003)
Inflamm Bowel Dis
, vol.9
, pp. 104-115
-
-
Storch, I.1
Sachar, D.2
Katz, S.3
-
5
-
-
0030016118
-
Immune-related manifestations of inflammatory bowel disease: a prospective study of 792 patients
-
Veloso F., Carvalho J., Magro F. Immune-related manifestations of inflammatory bowel disease: a prospective study of 792 patients. J Clin Gastroenterol 1996, 23:29-34.
-
(1996)
J Clin Gastroenterol
, vol.23
, pp. 29-34
-
-
Veloso, F.1
Carvalho, J.2
Magro, F.3
-
7
-
-
0037309550
-
Noninfectious lung pathology in patients with Crohn's disease
-
Casey M.B., Tazelaar H.D., Myers J.L., Hunninghake G.W., Kakar S., Kalra S.X., et al. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol 2003, 27:213-219.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 213-219
-
-
Casey, M.B.1
Tazelaar, H.D.2
Myers, J.L.3
Hunninghake, G.W.4
Kakar, S.5
Kalra, S.X.6
-
8
-
-
33847136182
-
Thoracic manifestations of inflammatory bowel disease
-
Black H., Mendoza M., Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007, 131:524-532.
-
(2007)
Chest
, vol.131
, pp. 524-532
-
-
Black, H.1
Mendoza, M.2
Murin, S.3
-
9
-
-
0024513777
-
Antibody secretion by human interstitial mononuclear cells from normal controls and inflammatory bowel disease patients
-
MacDermott R., Nash G., Nulum M. Antibody secretion by human interstitial mononuclear cells from normal controls and inflammatory bowel disease patients. Immunol Invest 1989, 18:449-457.
-
(1989)
Immunol Invest
, vol.18
, pp. 449-457
-
-
MacDermott, R.1
Nash, G.2
Nulum, M.3
-
10
-
-
0036174798
-
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission
-
Herrlinger K.R., Noftz M.K., Dalhoff K., Ludwig D., Stange E.F., Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002, 97:377-381.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 377-381
-
-
Herrlinger, K.R.1
Noftz, M.K.2
Dalhoff, K.3
Ludwig, D.4
Stange, E.F.5
Fellermann, K.6
-
11
-
-
0030871418
-
Pulmonary function abnormalities in patients with ulcerative colitis
-
Godet P.G., Cowie R., Woodman R.C., Sutherland L.R. Pulmonary function abnormalities in patients with ulcerative colitis. Am J Gastroenterol 1997, 92:1154-1156.
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 1154-1156
-
-
Godet, P.G.1
Cowie, R.2
Woodman, R.C.3
Sutherland, L.R.4
-
12
-
-
0021942293
-
Superoxide anion generation by alveolar macrophages in Crohn's disease
-
Wallaert B., Aerts C., Bonniere P., Cortot A., Tonnel A.B., Paris J.C., et al. Superoxide anion generation by alveolar macrophages in Crohn's disease. N Engl J Med 1985, 312:444-445.
-
(1985)
N Engl J Med
, vol.312
, pp. 444-445
-
-
Wallaert, B.1
Aerts, C.2
Bonniere, P.3
Cortot, A.4
Tonnel, A.B.5
Paris, J.C.6
-
13
-
-
0027156832
-
The lung in inflammatory bowel disease
-
Camus P., Piard F., Ashcroft T., Gal A.A., Colby T.V. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993, 72:151-183.
-
(1993)
Medicine (Baltimore)
, vol.72
, pp. 151-183
-
-
Camus, P.1
Piard, F.2
Ashcroft, T.3
Gal, A.A.4
Colby, T.V.5
-
14
-
-
0141854032
-
Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations
-
Foster R.A., Zander D.S., Mergo P.J., Valentine J.F. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis 2003, 9:308-315.
-
(2003)
Inflamm Bowel Dis
, vol.9
, pp. 308-315
-
-
Foster, R.A.1
Zander, D.S.2
Mergo, P.J.3
Valentine, J.F.4
-
15
-
-
0026704128
-
Lung disease associated with orally administered mesalamine for ulcerative colitis
-
Reinoso M.A., Schroeder K.W., Pisani R.J. Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 1992, 101:1469-1471.
-
(1992)
Chest
, vol.101
, pp. 1469-1471
-
-
Reinoso, M.A.1
Schroeder, K.W.2
Pisani, R.J.3
-
16
-
-
0029992069
-
Mesalamine-induced lung toxicity
-
Bitton A., Peppercorn M.A., Hanrahan J.P., Upton M.P. Mesalamine-induced lung toxicity. Am J Gastroenterol 1996, 91:1039-1040.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1039-1040
-
-
Bitton, A.1
Peppercorn, M.A.2
Hanrahan, J.P.3
Upton, M.P.4
-
17
-
-
0033775695
-
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence
-
Trisolini R., Dore R., Biagi F., Luinetti O., Pochetti P., Carrabino N., et al. Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:288-291.
-
(2000)
Sarcoidosis Vasc Diffuse Lung Dis
, vol.17
, pp. 288-291
-
-
Trisolini, R.1
Dore, R.2
Biagi, F.3
Luinetti, O.4
Pochetti, P.5
Carrabino, N.6
-
18
-
-
0034979191
-
Mesalamine-induced unilateral eosinophilic pneumonia
-
Saltzman K., Rossoff L.J., Gouda H., Tongia S. Mesalamine-induced unilateral eosinophilic pneumonia. AJR Am J Roentgenol 2001, 177:257.
-
(2001)
AJR Am J Roentgenol
, vol.177
, pp. 257
-
-
Saltzman, K.1
Rossoff, L.J.2
Gouda, H.3
Tongia, S.4
-
19
-
-
0034755367
-
Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine
-
Sossai P., Cappellato M.G., Stefani S. Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine. Mt Sinai J Med 2001, 68:389-395.
-
(2001)
Mt Sinai J Med
, vol.68
, pp. 389-395
-
-
Sossai, P.1
Cappellato, M.G.2
Stefani, S.3
-
20
-
-
33846921366
-
A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine
-
Nagy F., Molnar T., Makula E., Kiss I., Milassin P., Zollei E., et al. A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine. World J Gastroenterol 2007, 13:316-319.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 316-319
-
-
Nagy, F.1
Molnar, T.2
Makula, E.3
Kiss, I.4
Milassin, P.5
Zollei, E.6
-
21
-
-
34547653880
-
Severe pulmonary toxicity after Azathioprine/6-Mercaptopurine initiation for the treatment of inflammatory bowel disease
-
682-628
-
Ananthakrishnan A.N., Attila T., Otterson M.F., Lipchik R.J., Massey B.T., Komorowski R.A., et al. Severe pulmonary toxicity after Azathioprine/6-Mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol 2007, 41. 682-628.
-
(2007)
J Clin Gastroenterol
, vol.41
-
-
Ananthakrishnan, A.N.1
Attila, T.2
Otterson, M.F.3
Lipchik, R.J.4
Massey, B.T.5
Komorowski, R.A.6
-
22
-
-
0028675465
-
Cytotoxic drug-induced pulmonary disease in infants and children
-
Fauroux B., Meyer-Milsztain A., Boccon-Gibod L., Leverger G., Clément A., Biour M., et al. Cytotoxic drug-induced pulmonary disease in infants and children. Pediatr Pulmonol 1994, 18:347-355.
-
(1994)
Pediatr Pulmonol
, vol.18
, pp. 347-355
-
-
Fauroux, B.1
Meyer-Milsztain, A.2
Boccon-Gibod, L.3
Leverger, G.4
Clément, A.5
Biour, M.6
-
23
-
-
4444366271
-
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
-
Ardizzone S., Maconi G., Sampietro G.M., Russo A., Radice E., Colombo E., et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004, 127:730-740.
-
(2004)
Gastroenterology
, vol.127
, pp. 730-740
-
-
Ardizzone, S.1
Maconi, G.2
Sampietro, G.M.3
Russo, A.4
Radice, E.5
Colombo, E.6
-
24
-
-
0024457688
-
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity
-
Present D.H., Meltzer S.J., Krumholz M.P., Wolke A., Korelitz B.I. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989, 111:641-649.
-
(1989)
Ann Intern Med
, vol.111
, pp. 641-649
-
-
Present, D.H.1
Meltzer, S.J.2
Krumholz, M.P.3
Wolke, A.4
Korelitz, B.I.5
-
25
-
-
0021140488
-
Azathioprine-associated interstitial pneumonitis
-
Bedrossian C.W., Sussman J., Conklin R.H., Kahan B. Azathioprine-associated interstitial pneumonitis. Am J Clin Pathol 1984, 82:148-154.
-
(1984)
Am J Clin Pathol
, vol.82
, pp. 148-154
-
-
Bedrossian, C.W.1
Sussman, J.2
Conklin, R.H.3
Kahan, B.4
-
26
-
-
0033964302
-
Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients
-
Imokawa S., Colby T.V., Leslie K.O., Helmers R.A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000, 15:373-381.
-
(2000)
Eur Respir J
, vol.15
, pp. 373-381
-
-
Imokawa, S.1
Colby, T.V.2
Leslie, K.O.3
Helmers, R.A.4
-
27
-
-
20444430052
-
Fungal infections as a complication of therapy for sarcoidosis
-
Baughman R.P., Lower E.E. Fungal infections as a complication of therapy for sarcoidosis. QJM 2005, 98:451-456.
-
(2005)
QJM
, vol.98
, pp. 451-456
-
-
Baughman, R.P.1
Lower, E.E.2
-
28
-
-
34447320761
-
Histoplasmosis in a child with JRA on low-dose methotrexate
-
Kleiman M.B., Wheat L.J., Bowyer S. Histoplasmosis in a child with JRA on low-dose methotrexate. Rheumatology (Oxford) 2007, 46:1215-1216.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 1215-1216
-
-
Kleiman, M.B.1
Wheat, L.J.2
Bowyer, S.3
-
29
-
-
33745819196
-
Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
-
Pavy S., Constantin A., Pham T., Gossec L., Maillefert J.F., Cantagrel A., et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 2006, 73:388-395.
-
(2006)
Joint Bone Spine
, vol.73
, pp. 388-395
-
-
Pavy, S.1
Constantin, A.2
Pham, T.3
Gossec, L.4
Maillefert, J.F.5
Cantagrel, A.6
-
30
-
-
62949219864
-
Biological therapies for inflammatory bowel diseases
-
Erratum in: Gastroenterology 2009, 136:1844
-
Rutgeerts P., Vermeire S., Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009, 136:1182-1197. Erratum in: Gastroenterology 2009, 136:1844.
-
(2009)
Gastroenterology
, vol.136
, pp. 1182-1197
-
-
Rutgeerts, P.1
Vermeire, S.2
Van Assche, G.3
-
31
-
-
67651154470
-
Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
-
Hoentjen F., van Bodegraven A.A. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J Gastroenterol 2009, 15:2067-2073.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 2067-2073
-
-
Hoentjen, F.1
van Bodegraven, A.A.2
-
32
-
-
0035846326
-
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
-
Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
-
(2001)
N Engl J Med
, vol.345
, pp. 1098-1104
-
-
Keane, J.1
Gershon, S.2
Wise, R.P.3
Mirabile-Levens, E.4
Kasznica, J.5
Schwieterman, W.D.6
-
33
-
-
0036181410
-
Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment
-
Mayordomo L., Marenco J.L., Gomez-Mateos J., Rejon E. Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 2002, 31:44-45.
-
(2002)
Scand J Rheumatol
, vol.31
, pp. 44-45
-
-
Mayordomo, L.1
Marenco, J.L.2
Gomez-Mateos, J.3
Rejon, E.4
-
34
-
-
63949084931
-
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention
-
Garcia-Vidal C., Rodríguez-Fernández S., Teijón S., Esteve M., Rodríguez-Carballeira M., Lacasa J.M., et al. Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention. Eur J Clin Microbiol Infect Dis 2009, 28:331-337.
-
(2009)
Eur J Clin Microbiol Infect Dis
, vol.28
, pp. 331-337
-
-
Garcia-Vidal, C.1
Rodríguez-Fernández, S.2
Teijón, S.3
Esteve, M.4
Rodríguez-Carballeira, M.5
Lacasa, J.M.6
-
35
-
-
34248644322
-
Pneumocystis jiroveci (Carinii) pneumonia after infliximab therapy: a review of 84 cases
-
Kaur N., Mahl T. Pneumocystis jiroveci (Carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007, 52:1481-1484.
-
(2007)
Dig Dis Sci
, vol.52
, pp. 1481-1484
-
-
Kaur, N.1
Mahl, T.2
-
36
-
-
0347991877
-
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients
-
Colombel J.F., Loftus E.V., Tremaine W.J., Egan L.J., Harmsen W.S., Schleck C.D., et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004, 126:19-31.
-
(2004)
Gastroenterology
, vol.126
, pp. 19-31
-
-
Colombel, J.F.1
Loftus, E.V.2
Tremaine, W.J.3
Egan, L.J.4
Harmsen, W.S.5
Schleck, C.D.6
-
37
-
-
39749102391
-
Fungal infections complicating tumor necrosis factor alpha blockade therapy
-
Tsiodras S., Samonis G., Boumpas D.T., Kontoyiannis D.P. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008, 83:181-194.
-
(2008)
Mayo Clin Proc
, vol.83
, pp. 181-194
-
-
Tsiodras, S.1
Samonis, G.2
Boumpas, D.T.3
Kontoyiannis, D.P.4
-
38
-
-
41349088375
-
Risk factors for opportunistic infections in patients with inflammatory bowel disease
-
Toruner M., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Orenstein R., Sandborn W.J., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008, 134:929-936.
-
(2008)
Gastroenterology
, vol.134
, pp. 929-936
-
-
Toruner, M.1
Loftus, E.V.2
Harmsen, W.S.3
Zinsmeister, A.R.4
Orenstein, R.5
Sandborn, W.J.6
-
39
-
-
33744720092
-
Interstitial pneumonitis associated with infliximab therapy
-
Villenueve F., St-Pierre A., Haraoui P. Interstitial pneumonitis associated with infliximab therapy. J Rheumatology 2006, 33:1189-1193.
-
(2006)
J Rheumatology
, vol.33
, pp. 1189-1193
-
-
Villenueve, F.1
St-Pierre, A.2
Haraoui, P.3
-
40
-
-
0036106469
-
Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion
-
Riegert-Johnson D.L., Godfrey J.A., Myers J.L., Hubmayr R.D., Sandborn W.J., Loftus E.V. Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion. Inflamm Bowel Dis 2002, 8:186-191.
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 186-191
-
-
Riegert-Johnson, D.L.1
Godfrey, J.A.2
Myers, J.L.3
Hubmayr, R.D.4
Sandborn, W.J.5
Loftus, E.V.6
-
41
-
-
2442535188
-
Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease
-
Panagi S., Palka W., Korelitz B.I., Taskin M., Lessnau K.D. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease. Inflamm Bowel Dis 2004, 10:274-277.
-
(2004)
Inflamm Bowel Dis
, vol.10
, pp. 274-277
-
-
Panagi, S.1
Palka, W.2
Korelitz, B.I.3
Taskin, M.4
Lessnau, K.D.5
-
42
-
-
33644699177
-
Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis
-
Ostör A.J., Chilvers E.R., Somerville M.F., Lim A.Y., Lane S.E., Crisp A.J., et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 2006, 33:622-628.
-
(2006)
J Rheumatol
, vol.33
, pp. 622-628
-
-
Ostör, A.J.1
Chilvers, E.R.2
Somerville, M.F.3
Lim, A.Y.4
Lane, S.E.5
Crisp, A.J.6
-
43
-
-
60749103646
-
Optimizing conventional therapy for inflammatory bowel disease
-
Schwartz M., Cohen R. Optimizing conventional therapy for inflammatory bowel disease. Curr Gastroenterol Rep 2008, 10:585-590.
-
(2008)
Curr Gastroenterol Rep
, vol.10
, pp. 585-590
-
-
Schwartz, M.1
Cohen, R.2
-
44
-
-
0023490576
-
Pulmonary "cyclosporinoma" mimicking infection after heart transplantation
-
Gould K., Freeman R., Odom N.J., Locke T.J., McGregor C.G. Pulmonary "cyclosporinoma" mimicking infection after heart transplantation. J Heart Transplant 1987, 6:375-377.
-
(1987)
J Heart Transplant
, vol.6
, pp. 375-377
-
-
Gould, K.1
Freeman, R.2
Odom, N.J.3
Locke, T.J.4
McGregor, C.G.5
-
45
-
-
0031068167
-
Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia
-
Quan V.A., Saunders B.P., Hicks B.H., Sladen G.E. Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia. BMJ 1997, 314:363-364.
-
(1997)
BMJ
, vol.314
, pp. 363-364
-
-
Quan, V.A.1
Saunders, B.P.2
Hicks, B.H.3
Sladen, G.E.4
-
46
-
-
9844220857
-
Short-and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group
-
Van Gossum A., Schmit A., Adler M., Chioccioli C., Fiasse R., Louwagie P., et al. Short-and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group. Acta Gastroenterol Belg 1997, 60:197-200.
-
(1997)
Acta Gastroenterol Belg
, vol.60
, pp. 197-200
-
-
Van Gossum, A.1
Schmit, A.2
Adler, M.3
Chioccioli, C.4
Fiasse, R.5
Louwagie, P.6
-
48
-
-
59949105756
-
Medscape. Diagnosis and management of fistulizing Crohn's disease
-
Nielsen O.H., Rogler G., Hahnloser D., Thomsen O.Ø. Medscape. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009, 6:92-106.
-
(2009)
Nat Clin Pract Gastroenterol Hepatol
, vol.6
, pp. 92-106
-
-
Nielsen, O.H.1
Rogler, G.2
Hahnloser, D.3
Thomsen, O.Ø.4
-
49
-
-
38849124378
-
Fistulizing Crohn's disease
-
Felley C., Mottet C., Juillerat P., Pittet V., Froehlich F., Vader J.P., et al. Fistulizing Crohn's disease. Digestion 2007, 76:109-112.
-
(2007)
Digestion
, vol.76
, pp. 109-112
-
-
Felley, C.1
Mottet, C.2
Juillerat, P.3
Pittet, V.4
Froehlich, F.5
Vader, J.P.6
-
50
-
-
0029164586
-
Colobronchial fistula due to Crohn's disease
-
Karmy-Jones R., Chagpar A., Vallieres E., Hamilton S. Colobronchial fistula due to Crohn's disease. Ann Thorac Surg 1995, 60:446-448.
-
(1995)
Ann Thorac Surg
, vol.60
, pp. 446-448
-
-
Karmy-Jones, R.1
Chagpar, A.2
Vallieres, E.3
Hamilton, S.4
-
51
-
-
0035081511
-
Recurrent pneumonia from an ileobronchial fistula complicating Crohn's disease
-
Gumbo T., Rice T.W., Mawhorter S. Recurrent pneumonia from an ileobronchial fistula complicating Crohn's disease. J Clin Gastroenterol 2001, 32:365-367.
-
(2001)
J Clin Gastroenterol
, vol.32
, pp. 365-367
-
-
Gumbo, T.1
Rice, T.W.2
Mawhorter, S.3
-
52
-
-
0036207519
-
Infliximab treatment of an esophagobronchial fistula in a patient with extensive Crohn's disease of the esophagus
-
Ho I.K., Guarino D.P., Pertsovskiy Y., Cerulli M.A. Infliximab treatment of an esophagobronchial fistula in a patient with extensive Crohn's disease of the esophagus. J Clin Gastroenterol 2002, 34:488-489.
-
(2002)
J Clin Gastroenterol
, vol.34
, pp. 488-489
-
-
Ho, I.K.1
Guarino, D.P.2
Pertsovskiy, Y.3
Cerulli, M.A.4
-
53
-
-
33746680515
-
Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx"
-
Rieder F., Hamer O., Gelbmann C., Schölmerich J., Gross V., Feuerbach S., et al. Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx". Z Gastroenterol 2006, 44:599-602.
-
(2006)
Z Gastroenterol
, vol.44
, pp. 599-602
-
-
Rieder, F.1
Hamer, O.2
Gelbmann, C.3
Schölmerich, J.4
Gross, V.5
Feuerbach, S.6
-
54
-
-
20144368232
-
Oesophago-bronchial fistula causing cough and recurrent lower respiratory tract infections in a patient with Crohn's disease
-
Brittenden J., Hosker H.S., Healey C., Porter G. Oesophago-bronchial fistula causing cough and recurrent lower respiratory tract infections in a patient with Crohn's disease. Hosp Med 2005, 66:310-311.
-
(2005)
Hosp Med
, vol.66
, pp. 310-311
-
-
Brittenden, J.1
Hosker, H.S.2
Healey, C.3
Porter, G.4
-
55
-
-
53049097281
-
Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2
-
Franke A., Fischer A., Nothnagel M., Becker C., Grabe N., Till A., et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 2008, 135:1207-1215.
-
(2008)
Gastroenterology
, vol.135
, pp. 1207-1215
-
-
Franke, A.1
Fischer, A.2
Nothnagel, M.3
Becker, C.4
Grabe, N.5
Till, A.6
-
56
-
-
0030691135
-
Crohn's disease and sarcoidosis: systemic granulomatosis?
-
Fellermann K., Stahl M., Dahlhoff K., Amthor M., Ludwig D., Stange E.F. Crohn's disease and sarcoidosis: systemic granulomatosis?. Eur J Gastroenterol Hepatol 1997, 9:1121-1124.
-
(1997)
Eur J Gastroenterol Hepatol
, vol.9
, pp. 1121-1124
-
-
Fellermann, K.1
Stahl, M.2
Dahlhoff, K.3
Amthor, M.4
Ludwig, D.5
Stange, E.F.6
-
57
-
-
0028806183
-
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature
-
Fries W., Grassi S.A., Leone L., Giacomin D., Galeazzi F., Naccarato R., et al. Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature. Scand J Gastroenterol 1995, 30:1221-1223.
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 1221-1223
-
-
Fries, W.1
Grassi, S.A.2
Leone, L.3
Giacomin, D.4
Galeazzi, F.5
Naccarato, R.6
-
58
-
-
0036362440
-
Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease
-
Reynolds H.Y. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung 2002, 180:281-299.
-
(2002)
Lung
, vol.180
, pp. 281-299
-
-
Reynolds, H.Y.1
-
59
-
-
0018889392
-
Crohn's disease associated with Wegener's granulomatosis
-
Wechsler B., Couderc J.L., Tucat G., Beaufils H., Godeau P. Crohn's disease associated with Wegener's granulomatosis. Gastroenterol Clin Biol 1980, 4:356-361.
-
(1980)
Gastroenterol Clin Biol
, vol.4
, pp. 356-361
-
-
Wechsler, B.1
Couderc, J.L.2
Tucat, G.3
Beaufils, H.4
Godeau, P.5
-
60
-
-
12244275726
-
NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis
-
Newman B., Rubin L.A., Siminovitch K.A. NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis. J Rheumatol 2003, 30:305-307.
-
(2003)
J Rheumatol
, vol.30
, pp. 305-307
-
-
Newman, B.1
Rubin, L.A.2
Siminovitch, K.A.3
-
61
-
-
33749320050
-
Inflammatory bowel disease and lung
-
Ceyhan B. Inflammatory bowel disease and lung. Tuberk Toraks 2006, 54:292-298.
-
(2006)
Tuberk Toraks
, vol.54
, pp. 292-298
-
-
Ceyhan, B.1
-
62
-
-
0021840821
-
Pulmonary vasculitis complicating ulcerative colitis
-
Sargent D., Sessions J., Fairman P. Pulmonary vasculitis complicating ulcerative colitis. South Med J 1985, 78:624-625.
-
(1985)
South Med J
, vol.78
, pp. 624-625
-
-
Sargent, D.1
Sessions, J.2
Fairman, P.3
-
63
-
-
42449091641
-
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects
-
Papa A., Scaldaferri F., Danese S., Guglielmo S., Roberto I., Bonizzi M., et al. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Dig Dis 2008, 26:149-155.
-
(2008)
Dig Dis
, vol.26
, pp. 149-155
-
-
Papa, A.1
Scaldaferri, F.2
Danese, S.3
Guglielmo, S.4
Roberto, I.5
Bonizzi, M.6
-
64
-
-
1642578940
-
Haemostasis in inflammatory bowel diseases: clinical relevance
-
van Bodegraven A.A. Haemostasis in inflammatory bowel diseases: clinical relevance. Scand J Gastroenterol Suppl 2003, 51-62.
-
(2003)
Scand J Gastroenterol Suppl
, pp. 51-62
-
-
van Bodegraven, A.A.1
-
65
-
-
66949138571
-
Risk of arterial thrombotic events in inflammatory bowel disease
-
Ha C., Magowan S., Accortt N.A., Chen J., Stone C.D. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009, 104:1445-1451.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1445-1451
-
-
Ha, C.1
Magowan, S.2
Accortt, N.A.3
Chen, J.4
Stone, C.D.5
-
66
-
-
21244487777
-
Therapy insight: Vascular complications in patients with inflammatory bowel disease
-
Koutroubakis I.E. Therapy insight: Vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005, 2:266-272.
-
(2005)
Nat Clin Pract Gastroenterol Hepatol
, vol.2
, pp. 266-272
-
-
Koutroubakis, I.E.1
-
67
-
-
35148840268
-
Hospitalization-based major comorbidity of inflammatory bowel disease in Canada
-
Bernstein C.N., Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol 2007, 21:507-511.
-
(2007)
Can J Gastroenterol
, vol.21
, pp. 507-511
-
-
Bernstein, C.N.1
Nabalamba, A.2
-
68
-
-
0001837254
-
Extensive arterial and venous thrombosis complicating chronic ulcerative colitis
-
Bargen J.A., Barker N.W. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936, 58:17-31.
-
(1936)
Arch Intern Med
, vol.58
, pp. 17-31
-
-
Bargen, J.A.1
Barker, N.W.2
-
69
-
-
0035085024
-
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study
-
Bernstein C.N., Blanchard J.F., Houston D.S., Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.
-
(2001)
Thromb Haemost
, vol.85
, pp. 430-434
-
-
Bernstein, C.N.1
Blanchard, J.F.2
Houston, D.S.3
Wajda, A.4
-
70
-
-
0022656226
-
Vascular complications of inflammatory bowel disease
-
Talbot R.W., Heppel J., Dozois R.R., Beart R.W. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986, 61:140-145.
-
(1986)
Mayo Clin Proc
, vol.61
, pp. 140-145
-
-
Talbot, R.W.1
Heppel, J.2
Dozois, R.R.3
Beart, R.W.4
-
71
-
-
1542493341
-
Venous thromboembolism in inflammatory bowel disease
-
Solem C.A., Loftus E.V., Tremaine W.J., Sandborn W.J. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004, 99:97-101.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 97-101
-
-
Solem, C.A.1
Loftus, E.V.2
Tremaine, W.J.3
Sandborn, W.J.4
-
72
-
-
0032979156
-
Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease
-
Novacek G., Miehsler W., Kapiotis S., Katzenschlager R., Speiser W., Vogelsang H. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol 1999, 94:685-690.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 685-690
-
-
Novacek, G.1
Miehsler, W.2
Kapiotis, S.3
Katzenschlager, R.4
Speiser, W.5
Vogelsang, H.6
-
73
-
-
0033789463
-
Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
-
Oldenburg B., Fijnheer R., van der Griend R., vanBerge-Henegouwen G.P., Koningsberger J.C. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?. Am J Gastroenterol 2000, 95:2825-2830.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 2825-2830
-
-
Oldenburg, B.1
Fijnheer, R.2
van der Griend, R.3
vanBerge-Henegouwen, G.P.4
Koningsberger, J.C.5
-
74
-
-
14644443651
-
Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia
-
Oldenburg B., Van Tuyl B.A., van der Griend R., Fijnheer R., van Berge Henegouwen G.P. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Dig Dis Sci 2005, 50:235-240.
-
(2005)
Dig Dis Sci
, vol.50
, pp. 235-240
-
-
Oldenburg, B.1
Van Tuyl, B.A.2
van der Griend, R.3
Fijnheer, R.4
van Berge Henegouwen, G.P.5
-
75
-
-
0031749889
-
Large airway disease associated with inflammatory bowel disease
-
Spira A., Grossman R., Balter M. Large airway disease associated with inflammatory bowel disease. Chest 1998, 113:1723-1726.
-
(1998)
Chest
, vol.113
, pp. 1723-1726
-
-
Spira, A.1
Grossman, R.2
Balter, M.3
-
76
-
-
0033008607
-
Constrictive bronchiolitis and ulcerative colitis
-
Ward H., Fisher K.L., Waghray R., Wright J.L., Card S.E., Cockcroft D.W. Constrictive bronchiolitis and ulcerative colitis. Can Respir J 1999, 6:197-200.
-
(1999)
Can Respir J
, vol.6
, pp. 197-200
-
-
Ward, H.1
Fisher, K.L.2
Waghray, R.3
Wright, J.L.4
Card, S.E.5
Cockcroft, D.W.6
-
77
-
-
41149137036
-
Prevalence of inflammatory bowel disease in patients with airways disease
-
Raj A.A., Birring S.S., Green R., Grant A., de Caestecker J., Pavord I.D. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med 2008, 102:780-785.
-
(2008)
Respir Med
, vol.102
, pp. 780-785
-
-
Raj, A.A.1
Birring, S.S.2
Green, R.3
Grant, A.4
de Caestecker, J.5
Pavord, I.D.6
-
78
-
-
24144497765
-
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study
-
Bernstein C.N., Wajda A., Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005, 129:827-836.
-
(2005)
Gastroenterology
, vol.129
, pp. 827-836
-
-
Bernstein, C.N.1
Wajda, A.2
Blanchard, J.F.3
-
79
-
-
0033980624
-
Clinical and radiological characteristics of lung disease in inflammatory bowel disease
-
Mahadeva R., Walsh G., Flower C.D., Shneerson J.M. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Resp J 2000, 15:41-48.
-
(2000)
Eur Resp J
, vol.15
, pp. 41-48
-
-
Mahadeva, R.1
Walsh, G.2
Flower, C.D.3
Shneerson, J.M.4
-
80
-
-
54949105406
-
Case 33-2008: a 63year old woman with dyspnea on exertion
-
Wener C.M., Muse V.V., Mrk E.J. Case 33-2008: a 63year old woman with dyspnea on exertion. NEJM 2008, 339:1823-1832.
-
(2008)
NEJM
, vol.339
, pp. 1823-1832
-
-
Wener, C.M.1
Muse, V.V.2
Mrk, E.J.3
-
81
-
-
0034753178
-
CT signs and patterns of lung disease
-
Cellins J. CT signs and patterns of lung disease. Radiol Clin North America 2001, 39:1115-1135.
-
(2001)
Radiol Clin North America
, vol.39
, pp. 1115-1135
-
-
Cellins, J.1
-
82
-
-
1542302728
-
Bronchoalveolar lavage in drug-induced lung disease
-
Costabel U., Uzaslan E., Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 2004, 25:637-649.
-
(2004)
Clin Chest Med
, vol.25
, pp. 637-649
-
-
Costabel, U.1
Uzaslan, E.2
Guzman, J.3
-
85
-
-
33751383819
-
Uselfuness of oropharyngeal washings for identifying Pneumocystis jirovecii carriers
-
Respaldiza N., Montes-Cano M.A., Friaza V. Uselfuness of oropharyngeal washings for identifying Pneumocystis jirovecii carriers. J Eukaryot Microbiol 2006, 53:100S-101S.
-
(2006)
J Eukaryot Microbiol
, vol.53
-
-
Respaldiza, N.1
Montes-Cano, M.A.2
Friaza, V.3
-
86
-
-
59849123907
-
Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization
-
Wissmann G., Varela J.M., Calderon E.J. Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization. Inflamm Bowel Dis 2008, 14:1751-1752.
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 1751-1752
-
-
Wissmann, G.1
Varela, J.M.2
Calderon, E.J.3
|